These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 705009)

  • 1. Mitomycin C: experience in the United States, with emphasis on gastric cancer.
    Schein PS; MacDonald JS; Hoth D; Woolley PV
    Recent Results Cancer Res; 1978; 63():148-51. PubMed ID: 705009
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitomycin C: experience in the United States, with emphasis on gastric cancer.
    Schein PS; Macdonald JS; Hoth D; Wooley PV
    Cancer Chemother Pharmacol; 1978; 1(2):73-5. PubMed ID: 750107
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of 47 patients with stomach cancer treated with mitomycin C].
    Paolucci R
    Cancro; 1971; 24(3):153-9. PubMed ID: 4949673
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dosage and its safety in intraperitoneal high dose mitomycin C administration as postoperative adjuvant therapy for gastric cancer].
    Hiratsuka M; Ogawa A; Ohigashi H; Kameyama M; Sasaki Y; Ishikawa O; Kabuto T; Fukuda I; Furukawa H; Imaoka S
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1574-9. PubMed ID: 3141534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of mitomycin given in massive dose intraoperatively in cases of gastric cancer as assessed in terms of postoperative serum LDH isoenzyme patterns].
    Asaki S; Sugishita T; Ogawa N; Maehara T; Endou K; Yoshida S; Tanaka S; Okada K; Matsumoto S; Matsumoto A
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1503-11. PubMed ID: 3183458
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience of a combination chemotherapy consisting of 5-FU, MMC, and FT-207--side effects against kidney].
    Yamada F; Kagami H; Fukutome A; Mastumine T; Miura T
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2049-54. PubMed ID: 6412636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of gastric cancer--combination chemotherapy of mitomycin C, 5-fluorouracil and cytosine arabinoside].
    Suga S; Hirota Y; Shimaji T; Koide A; Iwata T
    Gan No Rinsho; 1972 Mar; 18(3):209-13. PubMed ID: 5063950
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.
    De Jager RL; Magill GB; Golbey RB; Krakoff IH
    Cancer Treat Rep; 1976 Sep; 60(9):1373-5. PubMed ID: 1016970
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
    Crocker J; Jones EL
    J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
    Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM
    Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitomycin (Mutamycin).
    Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
    [No Abstract]   [Full Text] [Related]  

  • 13. Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence.
    Imanaga H; Nakazato H
    World J Surg; 1977 Mar; 2(1):213-21. PubMed ID: 868069
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer.
    Cocconi G; DeLisi V; Di Blasio B
    Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of advanced gastric cancer with 5-fluorouracil versus mitomycin C.
    Gupta S
    J Surg Oncol; 1982 Oct; 21(2):94-6. PubMed ID: 6752585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Single chemotherapy with 5-fluorouracil or ftorafur and combination chemotherapy with mitomycin C and 5-fluorouracil for inoperable elderly gastric cancers].
    Fujii M; Murakami N
    Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):1-4. PubMed ID: 6408206
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of stomach cancer-with special reference to massive and intermittent administration of mitomycin C].
    Matsunaga F; Shimoyama T; Mikawa K; Ishiwata J; Kikuchi H
    Naika; 1966 Jun; 17(6):1101-15. PubMed ID: 5964528
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy of advanced gastric cancer.
    Gill PG; Jones AM; Abbott R
    Aust N Z J Surg; 1983 Jun; 53(3):237-40. PubMed ID: 6576775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Administration of mitomycin-C with an inactivator].
    Takahashi M; Yoshida K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):525-7. PubMed ID: 3932560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.